Gild needs to clear 82-84 areaI like it holding the dash line. The more it tests and holds, the power it accumulates.
4GILD trade ideas
$GILD - Please read the text below"Related: Yesterday, the WHO mistakenly posted draft documents of a Chinese study that showed remdesivir failed to improve patients' conditions.
Gilead countered that the study was underpowered for efficience since it was terminated early for low enrollment."
I'm not holding the stock.
Just had the feeling to post it!
Technically the stock remain strong!
Good-luck to all.
Gilead in tested channelGILD has seen positive price action YTD; due to combatting the COVID-19 with their drug Remdesivir.
Yesterday on the news, the trial on humans which was set in China to prove the effectivity of the drug, apparently "failed". However... The price just took us to the lower part of the channel , meaning the Risk-Reward-Ratio is at a good stance.
A close below the 50sma would change the sentiment, and remove us from the channel.
GILEAD Short Term Uptrend Trade PlanTrade Plan for Gilead Sciences.
Will look to enter at bottom of uptrend channel (75.3) , Stop Loss once uptrend broken (74).
Target Price at 86. Potential Price at 96. Personally will take profit at resistances as insurance.
Upside for Gilead:
1a) Possible treatment for Covid-19 (Remdesivir)
1b) Possible 2nd wave of virus
2) Possible FDA approval of Arthritis drug
Downside for Gilead:
1) Leaked report of Remdesivir failing in China randomized trial, which was cancelled early due to low enrollment numbers. Bears clinging on hopes that the conclusion was inaccurate due to short duration of study
$GILD Holds Bullish Posture as Key Data Looms for Top TreatmentGILD is the leader on the treatment side of the game with its remdesivir asset. The market will likely react to every new development. But the chart is very constructive at this point.
However, everything will depend on new data from trials now underway around the world.
Mainstream media has trashed Chloroquine and sold GileadThe new drug by Gilead will make certain people filthy rich
GILD just watch the boxInside the box my bias is short. Above the box my bias is long.
Targets = dotted black lines. Beware massive news risk with this name.
It can explode in the either direction on one tweet.
GILD Looking for a Long Entry After the Gap UpSUMMARY: Looking for a long entry on Gilead Sciences (GILD) after the gap up on news of a COVID treatment.
HEADLINE: Looking for a Long Entry After the Gap Up
TICKER: GILD
STRATEGY USED: Silver Scalper
Trend Confirmation = Range MA
Entry Signal = Bull/Bear Power
Exit Signal = Bull/Bear Power OR Range MA
---
DESCRIPTION:
1. With this strategy we enter long on Bull signals and exit on Bear signals when the trend is bullish.
2. The current trend on GILD is bullish according to our Alpha RMA (Green bar color).
3. We are currently looking for a Bull signal for a long entry.
4. We expect a stop and go off of S1 to get our long entry.
5. If we get the long entry at S1 we will be looking at R1 to see how the price reacts.
6. If S1 can't hold we will watching for a Bull signal in the S2 range.
---
NOTE: We conduct market analysis on a daily basis from a trend trading perspective using our own in house built tools. If you like any of the content we provide please leave a like and a follow to show your appreciation.
Gild updateIn the recent activities, every pop was sold. However, the stock has been making well "planned" higher lows. If it can close above at a local new high, you know what to do....
GileadGILD- If you didn't hear the news, yesterday Gilead labs were accredited with a drug that has been positively treating COVID19 patients. I checked the price and it is very expensive already. I had a look at the chart today and noticed that the last time this stock crossed golden (50/200 MA) on the weekly, it skyrocketed. On top of that, it held support like a champ. That moment is about to happen yet again. It is high risk due to price, you have to allocate less shares to spare your capital and an appropriate stop loss is at the weekly 200 MA. You must be ok to lose about $12 a share if the trade goes south but I see a massive opportunity in the works.
Gilead lifts the entire marketOptimism that Remdesivir is effective in the fight against Covid-19 has lifted the markets today
STAT reports that a Chicago hospital treating severe Covid-19 patients with Gilead Sciences’(GILD) antiviral medicine remdesivir is; "seeing rapid recoveries in fever and respiratory symptoms, with nearly all patients discharged in less than a week"
FOMO ON FRIDAYDespite this being a long term investment since trials take over a year to be proven. This will make a good stock for short selling because of FOMO on fridays from new investors.
It's already all over the major media.
5 wave up? Did not expect this. Been holding Jan 80c during his roller-coaster..... Had too much fun
$GILD Gets Ready to Wag the DowGILD shares will open in the $90 area, it would appear (on Thursday evening). The hints on Remdesivir results for COVID-19 treatment suggest a significant response among severe patients.
Given that the world hangs in the balance, the stakes couldn't be higher. This stock will be the tail wagging the S&P for the next week.
Trade Journal: Long $GILD - 3/12/2020This is not my typical type of setup, however the prospects of GILD look very inciting. GILD is currently working on a coronavirus vaccine and is the closest to having a FDA approved vaccine in the future. Any positive announcements could cause GILD to spike in price as coronavirus fears continue. On the weekly chart, there is clear bottoming price action followed by accumulation recently due to the coronavirus news. The past few days, GILD has retraced back to it's breakout level due to the overall market weakness.
On the daily chart, GILD retraced to and rejected the high volume node in the 62-68 area.
Since this trade is outside of my usual timeframe, I am using 1/3rd risk on this trade.
Entry - 68.86
Stop loss - 61.90
Target - 80-90
This is considered a long term trade. I will exit depending on the trend on the daily chart rather than the 30m chart.
Easy Swing?GILD is moving with the news these days but the risk vs. reward is looking good, even after coming of the Double Top. I would love to see it bounce of the trend line and buy around $71 for a easy swing to an $80 target. Any good news can make this happen sooner than later. Regardless of the outcome of the trials, big pharma is one of the safest spots to invest right now in my opinion. Take this all with a grain of salt and do your own homework. I honestly have no idea what I'm talking about but just throwing up some ideas to look back at later.
GILD support trendlineA trendline derives its authority from the number of times it has been touched or approached, the larger the number, the greater the significance.
